Hong Kong Construction Stock News

Be Friends Holding stock closed at HK$0.83 on the day of its H1 2026 results, with the market barely moving over the past week and only a modest gain over the past month. The muted reaction contrasts with earnings that paint a very different picture. Basic earnings per share for the half year came in at ¥0.0622 and trailing twelve month basic earnings per share reached ¥0.087298. That performance underpins a P/E of 8.2x, which is well below both peer and industry averages and keeps the long...

LEPU ScienTech Medical Technology (Shanghai) walked into this earnings day with the stock up over 22% across the past three months and trading on a richer P/E than the Hong Kong medical equipment sector. The headline today is profit quality meeting a valuation stress test. First half 2026 basic earnings per share of C¥0.4226 and net income of C¥146.5 million sit against a trailing net margin of 40.2%, which is well below last year. The key question for the market is whether that margin...

MicroTech Medical came into this earnings print with a premium story and a bruised share price, down about 9% over the past three months even as the trailing P/E hovered around 31x. The headline from the new half year numbers is simple. Profitability is now firmly in place, with basic earnings per share at ¥0.10 and net income at about ¥40.3m for H1 2026, turning last year’s small loss into a clean profit. For a medtech stock priced for growth, that shift in the income statement is what the...

Shenzhen Xunce Technology walked into this earnings day with a bruised share price, down sharply over the past three months, yet still carrying a rich growth stock label. The stock closed at HK$137.10 on 21 August, hardly a bargain tag for a high volatility story. The headline from the half year numbers is simple. Shenzhen Xunce Technology has moved firmly back into the black, with basic earnings per share of ¥0.22 and net income of ¥72.51m. That profit turn, following recent losses, is what...

Capital Environment Holdings went into this earnings day priced like a problem stock, with the shares at HK$0.08 and down over the past week and quarter. The latest half year results tell a different story. Net income excluding extra items reached ¥211.109m on revenue of ¥1,859.171m, and trailing earnings per share of ¥0.020801 now sit against a P/E of 3.3x. For a waste and environmental services operator often viewed through a risk lens because of weak interest coverage, the headline this...

The market has spent the past week marking Antengene lower, with the stock down about 10% over seven days, yet the latest numbers tell a very different story. H1 2026 landed with a sharp swing into profit, with basic earnings per share at ¥0.34 and net income of ¥216.345 million on revenue of ¥513.076 million. For a high P/E stock trading at about 42.4x trailing earnings, this move into the black is the headline. The key question now is whether this profitability burst can justify that...

Shanghai Haohai Biological Technology heads into this earnings season with a stock that has slipped about 18% over the past three months, yet trades on a P/E of 20.7 that still sits below the broader Hong Kong biotech industry. The market has been fixated on dividend yield and headline earnings volatility. The key issue in this Q2 release is the profit squeeze behind those headlines. Trailing net margin is 6.5% compared with 15.4% a year earlier, and the period includes a large one-off loss...

CITIC Resources Holdings went into its H1 2026 earnings with the stock at HK$0.51, up over the past month but still weaker over the last quarter. The headline was not revenue growth; the story was profit. Basic earnings per share for the half came in at HK$0.0363, against modest earnings in H2 2025, with net income at HK$285.6m on HK$5.1b of revenue. Short term traders saw a low priced stock move. Longer term investors now have to weigh that profit rebound against a higher 13.2x trailing P/E...

Shanghai Henlius Biotech went into its H1 2026 earnings with a rich 38.7x P/E and a stock that had climbed 19.1% over the past month, so expectations were already elevated. The headline this time is about profitability pressure. Net profit margin over the last year sat at 12.4%, below the prior 14.3%, while trailing earnings growth of 0.8% lagged far behind the earlier five year pace. For a biotech priced above the sector average, that margin squeeze is likely to frame every conversation...

Recent commentary around BYD (SEHK:1211) focuses on a tension between its strong position in China’s new energy vehicle export market and fresh battery powered models, as well as rising concerns about valuation and intensifying global competition. See our latest analysis for BYD. At a latest share price of HK$93.15, BYD’s recent 7 day share price return of 5.55% and 30 day share price return of 5.08% point to short term momentum. In contrast, the 1 year total shareholder return decline of...

The market had China Leon Inspection Holding parked flat at HK$1.72 coming into the fresh H1 2026 numbers, with the stock going nowhere over the past week and barely moved over the past month. The calm price action sits awkwardly against an earnings story anchored on margin pressure. Net profit margin over the last year sat at 2.9% compared with 6.5% in the prior year, while the trailing P/E near 26x still prices the stock in line with peers. The key question for you is whether that valuation...

East Buy Holding stock closed at HK$20.22 on the day of its full year 2026 results, capping a rough three months with a decline of about 11%. That short term slide sits awkwardly against a very sharp earnings rebound, with trailing net margin at 9.5% compared with almost flat profitability a year ago and a trailing P/E of 33.6x that reflects high expectations. The real focus now is not today’s share price move; it is whether this earnings surge and improved margins can justify a valuation...

Investors walked into TUHU Car’s H1 2026 earnings with a stock that has drifted in the short term and fallen about 13.2% over the past 90 days, yet still carries a rich 27.5x P/E compared with cheaper Hong Kong commercial services peers. The headline from this report is margin pressure. Trailing net profit margin now sits at 1.7%, about half the 3.3% level from a year earlier, even with revenue for the half year at ¥8,777.8m. That squeeze is the pressure point the share price will have to...

Smart Globe Holdings entered this earnings release with a flat 7 day share price and a 90 day slide, yet the latest numbers point to a very different story. The stock closed at HK$1.50 today while the business reported sharply higher half year revenue of HK$190.734 million and Basic EPS of HK$0.0137. The real flashpoint is valuation. A P/E of 113.5x and a share price sitting above an estimated cash flow value of HK$1.08 mean today’s muted price reaction looks more like nerves about what is...

China Coal Energy walked into this earnings day with a stock that has barely moved over the past month but still trades on a single digit P/E and well below many valuation estimates. The headline from Q2 is a revenue haul of C¥38,947.4m that sits alongside C¥4,347.5m in net income, keeping profitability in focus for a sector where margins can swing hard with coal pricing. The market reaction will hinge on whether investors treat this as a confirmation of resilient earnings power or stay...

Jinxin Fertility Group stock closed at HK$2.23 on the day of its H1 2026 results, capping a flat month but a slightly positive week. The market look is calm. The earnings story is not. The headline is a clean return to profit, with basic earnings per share back in positive territory and net income from ongoing operations in the black for the trailing year. The key question for you is whether that profitability shift is being treated as routine, when it directly contrasts with the heavy loss...

The market has largely shrugged at Prosperous Industrial (Holdings), with the share price flat over the past week and weaker over three months, even as the latest half year numbers show a different story. H1 2026 revenue reached US$131.9m and net income came in at US$11.7m, while the stock trades on a trailing P/E of about 5x. The headline this time is the pressure on profitability, with the trailing net margin at 9.1% compared with 10.5% a year ago. That margin squeeze is what investors now...

Traders barely moved on Lung Kee Group Holdings today, with the stock flat over the past week and month even as fresh half year numbers hit the tape. That calm surface hides a harsher reality for longer term holders. The mould base manufacturer is still loss making, with first half 2026 earnings per share in a small loss and trailing 12 month income also in the red. The bigger story now sits on the balance between those persistent losses and a dividend yield of 16.55% that current earnings...

Tian An China Investments entered this earnings release with a stock that had edged up over the past month, yet still carried a loss over the last quarter and a reputation for weakening profitability. The market closed at HK$3.54 on the day of the release. The headline is simple and uncomfortable. H1 2026 delivered a net loss of HK$446.0m and a loss per share of HK$0.3042, while trailing twelve month earnings from continuing operations were also in the red. For a highly geared property...

Home Control International stock came into this earnings print treading water, roughly flat over the past week and down over the past quarter, even with the shares trading well below a discounted cash flow estimate. The new H1 2026 numbers drop straight into that valuation debate. Revenue of US$47.5m and net income of US$2.1m keep the business profitable, but the key tension for you is simple: the market is pricing a high trailing P/E against a stock that screens cheap on a discounted cash...

China Nonferrous Mining stock closed at HK$15.33 after the market had a full day to chew over the H1 2026 numbers. Short term traders saw a copper producer that has already climbed about 7.9% over the past week and roughly 8.8% over three months. The real story sits in profit power. Net income from ongoing operations reached US$834.7m on a trailing twelve month basis, and net profit margins are described as stronger than a year ago. For anyone thinking beyond the next few sessions, this...

Dongyue Group (SEHK:189) drew fresh attention after reporting higher half year sales of CNY 8,059.97 million and net income of CNY 1,026.98 million, with earnings per share of CNY 0.60. See our latest analysis for Dongyue Group. The earnings release has gone hand in hand with stronger share price momentum for Dongyue Group, with a 1 day share price return of 9.65% and year to date share price return of 24.49%. In addition, the 3 year total shareholder return of 103.51% highlights how the...

China Nonferrous Mining (SEHK:1258) caught investor attention after reporting higher first half 2026 sales and net income alongside an interim cash dividend, bringing earnings quality and shareholder cash returns into sharper focus. See our latest analysis for China Nonferrous Mining. The interim dividend and stronger half year earnings have coincided with a 7.1% 1 day share price return and an 8.8% 90 day share price return, while the 1 year total shareholder return of 87.6% and 5 year total...

China Petroleum & Chemical Corporation recently held a board meeting on 21 August 2026 to approve its interim results for the six months ended 30 June 2026, while Chinese refiners collectively secured about 24 million barrels of Saudi crude through a rare tender and long-term contracts. The combination of interim results approval and sizeable Saudi crude purchases highlights how Sinopec is managing both corporate governance milestones and physical supply security in a tight global energy...